First, we would like to thank Strauss et al.1 for their insight regarding the problem of primary graft dysfunction in response to our recent clinical review article.2
This article correctly points out that primary graft dysfunction, or perioperative allograft injury due to ischemia or reperfusion injury, is a significant problem after lung transplantation and is multifactorial. In 2017, the International Society for Heart and Lung Transplantation (Chicago, Illinois) published the clinical definition of primary graft dysfunction, which created a consensus for diagnosis, that can be consistently measured across centers at specific time points, and quantified severity.3 We appreciate Strauss et al. highlighting the other contributing factors to primary graft dysfunction, which include the disruption of the endothelial-epithelial alveolar membrane of the new allograft and the direct result of ischemia-reperfusion injury. Primary graft dysfunction is a diagnosis that well characterizes the clinical injury to the new allograft, with...